Your browser doesn't support javascript.
loading
Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls.
van Lierop, A H; Witteveen, J E; Hamdy, N A T; Papapoulos, S E.
Affiliation
  • van Lierop AH; Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
Eur J Endocrinol ; 163(5): 833-7, 2010 Nov.
Article in En | MEDLINE | ID: mdl-20817762
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parathyroid Hormone / Parathyroid Glands / Bone Morphogenetic Proteins / Hyperparathyroidism, Primary Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Endocrinol Journal subject: ENDOCRINOLOGIA Year: 2010 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parathyroid Hormone / Parathyroid Glands / Bone Morphogenetic Proteins / Hyperparathyroidism, Primary Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Endocrinol Journal subject: ENDOCRINOLOGIA Year: 2010 Document type: Article Affiliation country: Países Bajos Country of publication: Reino Unido